Acoziborole

DB13086InvestigationalSmall molecule

SCYX-7158 has been used in trials studying the treatment of Trypanosomiasis, Parasitic Diseases, Protozoan Infections, and Trypanosomiasis, African.

Mechanism: Pharmacologically active on Cleavage and polyadenylation specificity factor subunit 3
Curator reviewed
Formula / weight: C₁₇H₁₄BF₄NO₃ · 367.11 g/mol (avg)
Code names: SCYX-7158

Resolves to

Compound

Structure

InChIKeyPTYGDEXEGLDNAZ-UHFFFAOYSA-NSMILESCC1(C)OB(O)C2=CC(NC(=O)C3=CC=C(F)C=C3C(F)(F)F)=CC=C12

Targets

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Acoziborole, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.